1. Home
  2. PHGE vs SKK Comparison

PHGE vs SKK Comparison

Compare PHGE & SKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • SKK
  • Stock Information
  • Founded
  • PHGE 2015
  • SKK 2013
  • Country
  • PHGE Israel
  • SKK Singapore
  • Employees
  • PHGE N/A
  • SKK N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • SKK
  • Sector
  • PHGE Health Care
  • SKK
  • Exchange
  • PHGE Nasdaq
  • SKK NYSE
  • Market Cap
  • PHGE 13.3M
  • SKK 14.9M
  • IPO Year
  • PHGE N/A
  • SKK 2024
  • Fundamental
  • Price
  • PHGE $0.96
  • SKK $0.81
  • Analyst Decision
  • PHGE Strong Buy
  • SKK
  • Analyst Count
  • PHGE 2
  • SKK 0
  • Target Price
  • PHGE $13.50
  • SKK N/A
  • AVG Volume (30 Days)
  • PHGE 48.8K
  • SKK 212.2K
  • Earning Date
  • PHGE 04-02-2025
  • SKK 02-14-2025
  • Dividend Yield
  • PHGE N/A
  • SKK N/A
  • EPS Growth
  • PHGE N/A
  • SKK N/A
  • EPS
  • PHGE N/A
  • SKK N/A
  • Revenue
  • PHGE N/A
  • SKK $8,631,000.00
  • Revenue This Year
  • PHGE N/A
  • SKK N/A
  • Revenue Next Year
  • PHGE N/A
  • SKK N/A
  • P/E Ratio
  • PHGE N/A
  • SKK N/A
  • Revenue Growth
  • PHGE N/A
  • SKK N/A
  • 52 Week Low
  • PHGE $0.48
  • SKK $0.61
  • 52 Week High
  • PHGE $8.55
  • SKK $11.45
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 65.22
  • SKK N/A
  • Support Level
  • PHGE $0.87
  • SKK N/A
  • Resistance Level
  • PHGE $0.99
  • SKK N/A
  • Average True Range (ATR)
  • PHGE 0.08
  • SKK 0.00
  • MACD
  • PHGE 0.01
  • SKK 0.00
  • Stochastic Oscillator
  • PHGE 89.20
  • SKK 0.00

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About SKK SKK HOLDINGS LIMITED

SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are primarily the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.

Share on Social Networks: